Fibrobiologics Inc
fibrobiologics.comWhat Do They Do?
Develops fibroblast-based cell therapies for patients with chronic diseases, including wound-healing disorders, multiple sclerosis and degenerative disc disease.
10-K for FY2025, filed Feb 24, 2026We are a clinical-stage biotechnology company focused on developing and commercializing fibroblast-based therapies for patients suffering…View ↗
How Do They Make Money?
No revenue reported yet.
10-K for FY2025, filed Feb 24, 2026
How Are They Changing?
- Net income
-
Sources
10-Q for Q2 FY2026, filed Jul 31, 2026
−$4.1MView ↗
- ▼ −12% (Loss)
- vs −$4.7M in Q2 FY2025
-
Jul 24, 2026
Nasdaq determined the company’s securities should be delisted
The company said it would appeal the determination, which would stay further delisting actions through the hearing process.
Sources
8-K, filed Jul 24, 2026
On July 22, 2026, FibroBiologics, Inc. (the “Company”) received a Staff Determination letter (the “Staff Determination”) from the Listing…View ↗
Loading...
